The world made plans to end the transmission of HIV from mother to baby by 2020. And while the rate of infection among children has been going down, there are still millions of children living with HIV across the world. Several factors stand in the way of the successful eradication of the problem and a more effective HIV response.
Continue reading
Two biotech companies have announced their plans to develop vaccine-like HIV immunotherapy. The aim of the new product would be to teach the immune system to target the virus and get rid of it. Gilead Sciences, one of the companies in the partnership, already has extensive experience in the field of HIV medication development.
Continue reading
HIV PrEP is one of the most powerful tools in the fight against the virus, reducing the risk of infection by as much as 99 per cent. Until recently, however, PrEP was mainly available in Western countries. New programs and government efforts have increased the availability of PrEP in Africa. Sub-Saharan countries now account for more than 50 per cent of the world’s PrEP users.
Continue reading
While HIV has been around for over four decades already, there’s still a ton of misunderstanding about the condition. Myths and misconceptions about living with HIV have persisted through the years. It’s now time to talk what it’s really like to live with HIV and how the condition can be managed.
Continue reading
Will UNAIDS projections for ending the HIV and AIDS pandemic by 2030 come true or will these be hindered by the coronavirus pandemic?
Continue reading
A team from India has recently published its latest work that focuses on the development of HIV and novel coronavirus vaccines. The way the team tackles the two viruses is similar and it could potentially help for the creation of vaccines that work really well and that are inexpensive.
Continue reading
The latest national report from the UK shows that 2019 marks an important milestone. The rate of new HIV diagnoses has gone down significantly among all groups. The reduction is particularly notable among one high risk segment – gay and bisexual men.
Continue reading
A new study suggests new opportunities for the prevention of HIV through the use of injectable PrEP. The study focuses exclusively on women living in Sub-Saharan Africa and it suggests that cabotegravir could deliver much better results as a form of HIV prevention than Truvada.
Continue reading
The human immunodeficiency virus (HIV) compromises the functioning of the immune system. This is the main reason why healthcare professionals have expressed a lot of concern about the way HIV-positive people could be affected by Covid-19. Have their fears of negative outcomes come true? Here’s what data shows so far.
Continue reading
The World Health Organization (WHO) is constantly upgrading its recommendations for the treatment of HIV and AIDS. A new meta-analysis has now shown that dolutegravir, a type of antiretroviral medication, can be recommended as a first-line treatment option for people who are newly diagnosed as HIV positive.
Continue reading